{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:18:42Z","timestamp":1778678322588,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Hintergrund<\/jats:title>\n                    <jats:p>Der \u00dcbergang von der Kinder- und Jugendpsychiatrie (KJP) in die Erwachsenenpsychiatrie stellt f\u00fcr junge Menschen mit Aufmerksamkeitsdefizit\u2011\/Hyperaktivit\u00e4tsst\u00f6rung (ADHS) eine vulnerable Phase dar. Unterschiedliche Versorgungsstrukturen, therapeutische Konzepte und Verantwortlichkeitsmodelle f\u00fchren h\u00e4ufig zu Diskontinuit\u00e4ten und Behandlungsabbr\u00fcchen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ziel der Arbeit<\/jats:title>\n                    <jats:p>Darstellung zentraler Herausforderungen der Transition bei ADHS sowie Ableitung praxisorientierter Empfehlungen zur Optimierung des \u00dcbergangs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material und Methoden<\/jats:title>\n                    <jats:p>Narrative Auswertung aktueller Leitlinien (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften [AWMF], National Institute for Health and Clinical Exellence [NICE]), relevanter empirischer Literatur und qualitativer Studien zu Erfahrungen von Betroffenen, Familien und Behandelnden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>Als wesentliche Barrieren zeigen sich begrenztes Wissen der Jugendlichen \u00fcber ADHS und Behandlungsm\u00f6glichkeiten, ausgepr\u00e4gte Schwierigkeiten im Selbstmanagement, fehlende interdisziplin\u00e4re Abstimmung, geringe Kenntnis der Angebote im Erwachsenenbereich und regionale Engp\u00e4sse spezialisierter ADHS-Versorgung. Zus\u00e4tzlich erschweren divergierende Behandlungskulturen der Fachdisziplinen sowie der Wegfall elterlicher Unterst\u00fctzung nach Erreichen der Vollj\u00e4hrigkeit den \u00dcbergang.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diskussion<\/jats:title>\n                    <jats:p>ADHS ist eine persistierende neuroentwicklungsbedingte St\u00f6rung und erfordert eine kontinuierliche, lebensspannenorientierte Versorgung. Eine gelingende Transition setzt strukturierte, standardisierte Prozesse, verl\u00e4ssliche Kommunikation zwischen den beteiligten Systemen, den angepasst fortgef\u00fchrten Einbezug der Familie sowie spezialisierte Versorgungsangebote voraus. Zuk\u00fcnftige Modelle sollten entwicklungsorientierte und autonomief\u00f6rdernde Ans\u00e4tze von KJP und Erwachsenenpsychiatrie integrieren.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00115-026-01956-5","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:14:10Z","timestamp":1774876450000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ADHS im \u00dcbergang: Wie gelingt Kontinuit\u00e4t in der Versorgung?","ADHS in transition: how can continuity in treatment succeed?"],"prefix":"10.1007","volume":"97","author":[{"given":"Sarah","family":"Hohmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"1956_CR1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/a-1011-4198","volume":"87","author":"P Abzieher","year":"2019","unstructured":"Abzieher\u00a0P, Lipp\u00a0M, Staats\u00a0JH et\u00a0al (2019) Treatment in Adolescent Psychiatry: Results of a Germany-wide Survey. Fortschr Neurol Psychiatr 87:645\u2013652","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1956_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/jcpp.14036","volume":"65","author":"N Adamo","year":"2024","unstructured":"Adamo\u00a0N, Singh\u00a0SP, Bolte\u00a0S et\u00a0al (2024) Practitioner Review: Continuity of mental health care from childhood to adulthood for youths with ADHD - who, how and when? J\u00a0Child Psychol Psychiatry 65:1526\u20131537","journal-title":"J Child Psychol Psychiatry"},{"key":"1956_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jcpp.13561","volume":"63","author":"JK Anderson","year":"2022","unstructured":"Anderson\u00a0JK, Newlove-Delgado\u00a0T, Ford\u00a0TJ (2022) Annual Research Review: A systematic review of mental health services for emerging adults - moulding a precipice into a smooth passage. J\u00a0Child Psychol Psychiatry 63:447\u2013462","journal-title":"J Child Psychol Psychiatry"},{"key":"1956_CR4","unstructured":"Awmf (2018) S3\u00a0Leitlinie \u201eADHS bei Kindern, Jugendlichen und Erwachsenen\u201c. In:"},{"key":"1956_CR5","first-page":"141","volume":"114","author":"CJ Bachmann","year":"2017","unstructured":"Bachmann\u00a0CJ, Philipsen\u00a0A, Hoffmann\u00a0F (2017) ADHD in Germany: Trends in Diagnosis and Pharmacotherapy. Dtsch Arztebl Int 114:141\u2013148","journal-title":"Dtsch Arztebl Int"},{"key":"1956_CR6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1055\/a-1016-3288","volume":"87","author":"T Banaschewski","year":"2019","unstructured":"Banaschewski\u00a0T, Fegert\u00a0JM, Freyberger\u00a0H et\u00a0al (2019) Transition psychiatry - challenges and solutions. Fortschr Neurol Psychiatr 87:608\u2013615","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1956_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1192\/bjp.2019.131","volume":"217","author":"H Eke","year":"2020","unstructured":"Eke\u00a0H, Ford\u00a0T, Newlove-Delgado\u00a0T et\u00a0al (2020) Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study. Br J Psychiatry 217:616\u2013622","journal-title":"Br J Psychiatry"},{"key":"1956_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/cch.12718","volume":"46","author":"H Eke","year":"2020","unstructured":"Eke\u00a0H, Janssens\u00a0A, Newlove-Delgado\u00a0T et\u00a0al (2020) Clinician perspectives on the use of National Institute for Health and Care Excellence guidelines for the process of transition in Attention Deficit Hyperactivity Disorder. Child Care Health Dev 46:111\u2013120","journal-title":"Child Care Health Dev"},{"key":"1956_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","volume":"128","author":"SV Faraone","year":"2021","unstructured":"Faraone\u00a0SV, Banaschewski\u00a0T, Coghill\u00a0D et\u00a0al (2021) The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev 128:789\u2013818","journal-title":"Neurosci Biobehav Rev"},{"key":"1956_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone\u00a0SV, Bellgrove\u00a0MA, Brikell\u00a0I et\u00a0al (2024) Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primers 10:11","journal-title":"Nat Rev Dis Primers"},{"key":"1956_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105209","volume":"151","author":"CA Hartman","year":"2023","unstructured":"Hartman\u00a0CA, Larsson\u00a0H, Vos\u00a0M et\u00a0al (2023) Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit\/hyperactivity disorder: A substantive and methodological overview. Neurosci Biobehav Rev 151:105209","journal-title":"Neurosci Biobehav Rev"},{"key":"1956_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/dmcn.15320","volume":"65","author":"A Janssens","year":"2023","unstructured":"Janssens\u00a0A, Blake\u00a0S, Eke\u00a0H et\u00a0al (2023) Parenting roles for young people with attention-deficit\/hyperactivity disorder transitioning to adult services. Dev Med Child Neurol 65:136\u2013144","journal-title":"Dev Med Child Neurol"},{"key":"1956_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2021.10.035","volume":"132","author":"S Kittel-Schneider","year":"2022","unstructured":"Kittel-Schneider\u00a0S, Arteaga-Henriquez\u00a0G, Vasquez\u00a0AA et\u00a0al (2022) Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity? Neurosci Biobehav Rev 132:1157\u20131180","journal-title":"Neurosci Biobehav Rev"},{"key":"1956_CR14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s00103-020-03175-y","volume":"63","author":"A Philipsen","year":"2020","unstructured":"Philipsen\u00a0A, Dopfner\u00a0M (2020) ADHD in the transition to adulthood: prevalence, symptoms, risks, and care. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63:910\u2013915","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1956_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","volume":"43","author":"GV Polanczyk","year":"2014","unstructured":"Polanczyk\u00a0GV, Willcutt\u00a0EG, Salum\u00a0GA et\u00a0al (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 43:434\u2013442","journal-title":"Int J Epidemiol"},{"key":"1956_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-03813-6","volume":"22","author":"A Price","year":"2022","unstructured":"Price\u00a0A, Mitchell\u00a0S, Janssens\u00a0A et\u00a0al (2022) In transition with attention deficit hyperactivity disorder (ADHD): children\u2019s services clinicians\u2019 perspectives on the role of information in healthcare transitions for young people with ADHD. BMC Psychiatry 22:251","journal-title":"BMC Psychiatry"},{"key":"1956_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2284-3","volume":"19","author":"A Price","year":"2019","unstructured":"Price\u00a0A, Newlove-Delgado\u00a0T, Eke\u00a0H et\u00a0al (2019) In transition with ADHD: the role of information, in facilitating or impeding young people\u2019s transition into adult services. BMC Psychiatry 19:404","journal-title":"BMC Psychiatry"},{"key":"1956_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-024-01522-1","volume":"12","author":"IL Rasmussen","year":"2024","unstructured":"Rasmussen\u00a0IL, Schei\u00a0J, Orjasaeter\u00a0KB (2024) \u201cA bit lost\u201d-Living with attention deficit hyperactivity disorder in the transition between adolescence and adulthood: an exploratory qualitative study. BMC Psychol 12:20","journal-title":"BMC Psychol"},{"key":"1956_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06011-8","volume":"24","author":"E Roberti","year":"2024","unstructured":"Roberti\u00a0E, Scarpellini\u00a0F, Campi\u00a0R et\u00a0al (2024) Protocols for transitioning to adult mental health services for adolescents with ADHD. BMC Psychiatry 24:603","journal-title":"BMC Psychiatry"},{"key":"1956_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cch.13070","volume":"49","author":"F Scarpellini","year":"2023","unstructured":"Scarpellini\u00a0F, Bonati\u00a0M (2023) Transition care for adolescents and young adults with attention-deficit hyperactivity disorder (ADHD): A\u00a0descriptive summary of qualitative evidence. Child Care Health Dev 49:431\u2013443","journal-title":"Child Care Health Dev"},{"key":"1956_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","volume":"179","author":"MH Sibley","year":"2022","unstructured":"Sibley\u00a0MH, Arnold\u00a0LE, Swanson\u00a0JM et\u00a0al (2022) Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry 179:142\u2013151","journal-title":"Am J Psychiatry"},{"key":"1956_CR22","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1017\/S0033291721003901","volume":"53","author":"SP Singh","year":"2023","unstructured":"Singh\u00a0SP, Tuomainen\u00a0H, Bouliotis\u00a0G et\u00a0al (2023) Effect of managed transition on mental health outcomes for young people at the child-adult mental health service boundary: a randomised clinical trial. Psychol Med 53:2193\u20132204","journal-title":"Psychol Med"},{"key":"1956_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02707-9","volume":"20","author":"S Young","year":"2020","unstructured":"Young\u00a0S, Adamo\u00a0N, Asgeirsdottir\u00a0BB et\u00a0al (2020) Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit\/ hyperactivity disorder in girls and women. BMC Psychiatry 20:404","journal-title":"BMC Psychiatry"},{"key":"1956_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1013-4","volume":"16","author":"S Young","year":"2016","unstructured":"Young\u00a0S, Adamou\u00a0M, Asherson\u00a0P et\u00a0al (2016) Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network. BMC Psychiatry 16:301","journal-title":"BMC Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01956-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:24:34Z","timestamp":1778675074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01956-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Hohmann h\u00e4lt Vortr\u00e4ge im Rahmen einer Veranstaltungsreihe von Consilium\/Infectopharm. A.\u00a0Philipsen gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}